INmune Bio Inc. - Common stock (INMB) earnings
INMB earnings moved a median of +1.26% by the close. Quarterly and annual INMB reports and results, each read against the price at its own news timestamp. Back to the INMB overview →
32 measured INMB earnings events.
Where these INMB earnings landedvs 32 measured INMB earnings reactions
| Middle 50% of INMB earnings reactions | -2.14% to +4.57% |
|---|---|
| Median reaction (to close) | +1.26% |
| Measured reactions | 32 |
Point-in-time · zero look-ahead
Half of the 32 INMB earnings events with a measured close landed between -2.14% and +4.57%; 59% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Inmune Bio, Inc. For: Jun 30 | SEC filing · Form 10-Q | -1.78% | +5.84% | |
| INmune Bio Inc. Announces Second Quarter 2026 Results and Highlights Regulatory, Manufacturing and Clinical Progress | Press release | -1.78% | +5.84% | |
| INmune Bio Inc. to Report Second Quarter 2026 Financial Results and Provide Corporate Update on Thursday, August 6th | Press release | +0.73% | -1.13% | |
| Form 10-Q Inmune Bio, Inc. For: Mar 31 | SEC filing · Form 10-Q | +2.84% | +1.42% | |
| INmune Bio Inc. Announces First Quarter 2026 Results and Provides Business Update | Press release | +2.84% | +1.42% | |
| INmune Bio Inc. to Report First Quarter 2026 Financial Results and Provide Corporate Update on Thursday, May 7th | Press release | +2.25% | +7.52% | |
| Form 10-K Inmune Bio, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.90% | +1.80% | |
| Form 10-Q Inmune Bio, Inc. For: Sep 30 | SEC filing · Form 10-Q | +5.71% | +4.57% | |
| INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update | Press release | +5.71% | +4.57% | |
| INmune Bio Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on Thursday, October 30, 2025 | Press release | +1.68% | +0.00% | |
| Form 10-Q Inmune Bio, Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.46% | +6.67% | |
| INmune Bio Inc. Announces Second Quarter 2025 Results, Provides Business Update and Announces Management Changes | Press release | -0.46% | +6.67% | |
| INmune Bio Inc. to Report Second Quarter 2025 Financial Results and Provide Corporate Update on Thursday, August 7th | Press release | +0.37% | +1.11% | |
| Form 10-Q Inmune Bio, Inc. For: Mar 31 | SEC filing · Form 10-Q | -5.53% | -10.30% | |
| INmune Bio Inc. Announces First Quarter 2025 Results and Provides Business Update | Press release | -5.53% | -10.30% | |
| INmune Bio Inc. to Report First Quarter 2025 Financial Results and Provide Corporate Update on Thursday, May 8th | Press release | -1.68% | -2.71% | |
| Form 10-K Inmune Bio, Inc. For: Dec 31 | SEC filing · Form 10-K | +2.19% | -0.40% | |
| INmune Bio Inc. to Report Fourth Quarter 2024 Financial Results and Provide Corporate Update on March 27, 2025 | Press release | +1.45% | +0.36% | |
| Form 10-Q Inmune Bio, Inc. For: Sep 30 | SEC filing · Form 10-Q | +4.38% | +1.68% | |
| INmune Bio Inc. Announces Third Quarter 2024 Results and Provides Business Update | Press release | +4.38% | +1.68% | |
| INmune Bio Inc. to Report Third Quarter 2024 Financial Results and Provide Corporate Update on October 31, 2024 | Press release | -0.60% | +4.40% | |
| Form 10-Q Inmune Bio, Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.94% | +5.42% | |
| INmune Bio Inc. Announces Second Quarter 2024 Results and Provides Business Update | Press release | +1.94% | +5.42% | |
| INmune Bio Inc. to Report Second Quarter 2024 Financial Results and Provide a Corporate Update on Thursday, August 1, 2024 | Press release | +0.00% | +2.79% | |
| Form 10-Q Inmune Bio, Inc. For: Mar 31 | SEC filing · Form 10-Q | -2.44% | -6.09% | |
| INmune Bio Inc. Announces First Quarter 2024 Results and Provides Business Update | Press release | -2.44% | -6.09% | |
| INmune Bio Inc. to Report First Quarter 2024 Financial Results and Provide a Corporate Update on Thursday, May 9 | Press release | -0.45% | +0.27% | |
| Form 10-K/A Inmune Bio, Inc. For: Dec 31 | SEC filing · Form 10-K | -1.31% | -7.77% | |
| Form 10-K Inmune Bio, Inc. For: Dec 31 | SEC filing · Form 10-K | -2.04% | -1.96% | |
| INmune Bio Inc. to Report Fourth Quarter 2023 Financial Results and Provide a Corporate Update on Thursday, March 28 | Press release | +0.00% | -0.94% | |
| Form 10-Q Inmune Bio, Inc. For: Sep 30 | SEC filing · Form 10-Q | — | -3.82% | |
| INmune Bio Inc. Announces Third Quarter 2023 Results and Provides Business Update | Press release | — | -3.82% |
Keep exploring
More INMB: analyst actions → · SEC filings → · INMB overview →